Case Report
Accepted on 24 Apr 2026
Response to ivosidenib in patients with cholangiocarcinoma: a clinical perspective with illustrative cases
in Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers
Frontiers in Oncology
- 267 views
6 articles related to "Ivosidenib"
Articles
Review
Published on 23 Jun 2022
The Molecular Mechanisms of Resistance to IDH Inhibitors in Acute Myeloid Leukemia
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2022.931462
- 10,719 views
- 35 citations
Original Research
Published on 30 Mar 2021
Transcriptome Analysis of Ivosidenib-Mediated Inhibitory Functions on Non-Small Cell Lung Cancer
in Pharmacology of Anti-Cancer Drugs
Frontiers in Oncology
doi 10.3389/fonc.2021.626605
- 6,422 views
- 3 citations
Case Report
Published on 10 Mar 2023
Case report: Sustained complete remission with ivosidenib in a patient with relapsed, IDH1-mutated acute leukemia
in Blood Cancer
Frontiers in Hematology
doi 10.3389/frhem.2023.1134837
- 2,395 views
Review
Published on 17 May 2019
Mutant Isocitrate Dehydrogenase Inhibitors as Targeted Cancer Therapeutics
in Cancer Molecular Targets and Therapeutics
Frontiers in Oncology
doi 10.3389/fonc.2019.00417
- 41,784 views
- 233 citations
Original Research
Published on 07 Nov 2024
A real-world study of adverse drug reactions of two isocitrate dehydrogenase inhibitor based on the US FDA adverse event reporting system and VigiAccess databases
in Pharmacology of Anti-Cancer Drugs
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1489045
- 4,031 views
- 4 citations